EU regulators recommend yanking authorization for Novartis' sickle cell med Adakveo after phase 3 miss
26th May 2023 Uncategorised 0EU regulators recommend yanking authorization for Novartis’ sickle cell med Adakveo after phase 3 miss zbecker Fri, 05/26/2023 – 10:48 More: EU regulators recommend yanking authorization for Novartis' sickle cell med Adakveo after phase 3 miss Source: fierce
read more